These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8361761)

  • 41. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
    You M; Bose HR
    Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
    Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
    Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional and post-transcriptional regulation of kappaB-controlled genes by pp60v-src.
    Cabannes E; Vives MF; Bédard PA
    Oncogene; 1997 Jul; 15(1):29-43. PubMed ID: 9233775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
    Petrenko O; Ischenko I; Enrietto PJ
    Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.
    Inuzuka M; Ishikawa H; Kumar S; Gélinas C; Ito Y
    Oncogene; 1994 Jan; 9(1):133-40. PubMed ID: 8302572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M; Temin HM
    Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X; Gélinas C
    Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. v-Rel activates the proto-oncogene c-Jun promoter: a correlation with its transforming activity.
    Fujii M; Minamino T; Nomura M; Miyamoto K; Tanaka J; Seiki M
    Leukemia; 1997 Apr; 11 Suppl 3():402-4. PubMed ID: 9209405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M; Temin HM
    Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA; Pierce JW; Sonenshein GE
    Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The oncogenicity of jun.
    Vogt PK; Bos TJ; Mitsunobu F; Nishimura T; Monteclaro FS; Su HY
    Princess Takamatsu Symp; 1989; 20():127-34. PubMed ID: 2562177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transformation suppressor activity of a Jun transcription factor lacking its activation domain.
    Lloyd A; Yancheva N; Wasylyk B
    Nature; 1991 Aug; 352(6336):635-8. PubMed ID: 1907719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1.
    Miltenberger RJ; Farnham PJ; Smith DE; Stommel JM; Cornwell MM
    Cell Growth Differ; 1995 May; 6(5):549-56. PubMed ID: 7647038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.